Cyteir Therapeutics Inc 's

• CYT's Stock Performance relative to its Competitors

Zymeworks Inc Share Performance +2.22% Over The Past 5 Days

Zymeworks Inc Profile Zymeworks Inc is a biotechnology company that operates on a licensing and collaboration business model. They primarily generate revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, providing access to their proprietary drug development platform and expertise in protein engineering. This enables them to advance the development of novel bi-specific antibodies and therapeutic proteins for the treatment of various diseases and medical conditions. More about Zymeworks Inc 's Market Share

Nurix Therapeutics Inc Share Performance +45.90% This Quarter

Nurix Therapeutics Inc Profile Nurix Therapeutics Inc's business model involves developing targeted protein degradation therapies to treat diseases by modulating the body's cellular protein levels. More about Nurix Therapeutics Inc 's Market Share

Novabridge Biosciences Share Performance -3.70% Over The Past 5 Days

Novabridge Biosciences Profile The company develops drug candidates and conducts related research and development activities in China. More about Novabridge Biosciences's Market Share

Milestone Pharmaceuticals Inc Share Performance -19.44% This Quarter

Milestone Pharmaceuticals Inc Profile Milestone Pharmaceuticals Inc. is a pharmaceutical company that focuses on developing and commercializing innovative therapies for cardiovascular diseases. Their business model revolves around identifying unmet medical needs in the cardiovascular space and leveraging their expertise in drug development to create novel treatments. By conducting rigorous research, clinical trials, and collaborations, Milestone Pharmaceuticals aims to bring effective and safe medications to market, positively impacting patients' lives. More about Milestone Pharmaceuticals Inc 's Market Share

Mira Pharmaceuticals Inc Share Performance -48.31% This Year

Mira Pharmaceuticals Inc Profile Mira Pharmaceuticals Inc's business model is focused on the development and sale of pharmaceutical products, with a particular emphasis on research and innovation in the healthcare industry. More about Mira Pharmaceuticals Inc 's Market Share

Sources: Cyteir Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 4:59 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cyteir Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.